InsiderTrades

Form 4 for OM Outset Medical, Inc.

Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-20 · accession 0001140361-23-012810 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-21 2023-03-20 OM Brottem John L. GC S - Sale+OE $20.82 -4,130 61.6K -6% -$86.0K
D 2023-03-21 2023-03-20 OM Brottem John L. GC M - OptEx $9.48 +1,415 65.7K +2% +$13.4K
D 2023-03-21 2023-03-20 OM Brottem John L. GC M - OptEx $0.00 -1,415 21.2K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-20 S D 1,415 $20.82 64,312 D — —
2 Common Common Stock 2023-03-20 S D 2,715 $20.82 61,597 D — —
3 Common Common Stock 2023-03-20 M A 1,415 $9.48 65,727 D — — (F1) Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
4 Derivative Non-Qualified Stock Option (right to buy) 2023-03-20 M D 1,415 $0.00 21,218 D $9.48 · — to 2030-05-26 1,415 Common Stock (F3) This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.